Phase I Study in Advanced Solid Tumors
NCT00591292
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
indibulin
Sponsor
Alaunos Therapeutics